LB 1182 – Nebraska

Status: Inactive / Dead
Year Introduced: 2020

LB 1182 will require drug manufacturers to submit notification to the Nebraska Departmentof Health & Human Services within 60 days of receiving an action date from the Food and Drug Administration, that the marketing application for a new drug has been submitted. The bill also empowers state healthcare officials to conduct studies on drugs subject to price increases that may have significant impact on state expenditures.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found